Compile Data Set for Download or QSAR
Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 11118
TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287566BDBM50287566(CHEMBL4160797 | US11572354, Compound 10m)
Affinity DataIC50: 34nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287562BDBM50287562(CHEMBL4173383 | US11572354, Compound 10e)
Affinity DataIC50: 38nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287581BDBM50287581(CHEMBL4173791 | US11572354, Compound 10d)
Affinity DataIC50: 100nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287567BDBM50287567(CHEMBL4165309 | US11572354, Compound 10l)
Affinity DataIC50: 113nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287565BDBM50287565(CHEMBL4163084 | US11572354, Compound 10c)
Affinity DataIC50: 180nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 592245BDBM592245(US11572354, Compound G29)
Affinity DataIC50: 230nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 592244BDBM592244(US11572354, Compound G28)
Affinity DataIC50: 309nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287577BDBM50287577(CHEMBL4165466 | US11572354, Compound 10f)
Affinity DataIC50: 322nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287569BDBM50287569(CHEMBL4177139 | US11572354, Compound 10b)
Affinity DataIC50: 1.25E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287579BDBM50287579(CHEMBL4166936 | US11572354, Compound 9k)
Affinity DataIC50: 2.00E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287561BDBM50287561(CHEMBL4163441 | US11572354, Compound 9f)
Affinity DataIC50: 4.00E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287560BDBM50287560(CHEMBL4166521 | US11572354, Compound 10a)
Affinity DataIC50: 4.44E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287572BDBM50287572(CHEMBL4164194 | US11572354, Compound 10g)
Affinity DataIC50: 4.64E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287582BDBM50287582(CHEMBL4174828 | US11572354, Compound 9j)
Affinity DataIC50: 6.00E+3nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287570BDBM50287570(CHEMBL4165816 | US11572354, Compound 9a)
Affinity DataIC50: 1.30E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287573BDBM50287573(CHEMBL4159712 | US11572354, Compound 9h)
Affinity DataIC50: 1.90E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287575BDBM50287575(CHEMBL4175513 | US11572354, Compound 10j)
Affinity DataIC50: 2.10E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 592223BDBM592223(US11572354, Compound 9d)
Affinity DataIC50: 2.10E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287576BDBM50287576(CHEMBL4167644 | US11572354, Compound 10i)
Affinity DataIC50: 2.27E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287574BDBM50287574(CHEMBL4162371 | US11572354, Compound 9c)
Affinity DataIC50: 3.40E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287583BDBM50287583(CHEMBL4170293 | US11572354, Compound 9b)
Affinity DataIC50: 3.40E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase 2(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287572BDBM50287572(CHEMBL4164194 | US11572354, Compound 10g)
Affinity DataIC50: 4.25E+4nMAssay Description:A Standard reaction mixture (200 uL/well) containing 50 mM potassium phosphate buffer (pH 6.5), 20mM ascorbic acid (neutralized with NaOH), 200 ug/ml...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287564BDBM50287564(CHEMBL4175924 | US11572354, Compound 10k)
Affinity DataIC50: 4.48E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287584BDBM50287584(CHEMBL4170338 | US11572354, Compound 9i)
Affinity DataIC50: 5.00E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase 2(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287566BDBM50287566(CHEMBL4160797 | US11572354, Compound 10m)
Affinity DataIC50: 5.44E+4nMAssay Description:A Standard reaction mixture (200 uL/well) containing 50 mM potassium phosphate buffer (pH 6.5), 20mM ascorbic acid (neutralized with NaOH), 200 ug/ml...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase 2(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287581BDBM50287581(CHEMBL4173791 | US11572354, Compound 10d)
Affinity DataIC50: 7.01E+4nMAssay Description:A Standard reaction mixture (200 uL/well) containing 50 mM potassium phosphate buffer (pH 6.5), 20mM ascorbic acid (neutralized with NaOH), 200 ug/ml...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287568BDBM50287568(CHEMBL4172071 | US11572354, Compound 10h)
Affinity DataIC50: 8.33E+4nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase 2(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287567BDBM50287567(CHEMBL4165309 | US11572354, Compound 10l)
Affinity DataIC50: 8.40E+4nMAssay Description:A Standard reaction mixture (200 uL/well) containing 50 mM potassium phosphate buffer (pH 6.5), 20mM ascorbic acid (neutralized with NaOH), 200 ug/ml...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287580BDBM50287580(CHEMBL4177510 | US11572354, Compound 9e)
Affinity DataIC50: 1.00E+5nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287563BDBM50287563(CHEMBL4174143 | US11572354, Compound 9g)
Affinity DataIC50: 1.00E+5nMAssay Description:A standard reaction mixture (200uL/well) containing 50mM potassium phosphate buffer (pH 6.5), 20 mM ascorbic acid (neutralized with NaOH), 200 ug/mL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase 2(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287565BDBM50287565(CHEMBL4163084 | US11572354, Compound 10c)
Affinity DataIC50: 1.58E+5nMAssay Description:A Standard reaction mixture (200 uL/well) containing 50 mM potassium phosphate buffer (pH 6.5), 20mM ascorbic acid (neutralized with NaOH), 200 ug/ml...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase 2(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287577BDBM50287577(CHEMBL4165466 | US11572354, Compound 10f)
Affinity DataIC50: 2.00E+5nMAssay Description:A Standard reaction mixture (200 uL/well) containing 50 mM potassium phosphate buffer (pH 6.5), 20mM ascorbic acid (neutralized with NaOH), 200 ug/ml...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase 2(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287569BDBM50287569(CHEMBL4177139 | US11572354, Compound 10b)
Affinity DataIC50: 2.00E+5nMAssay Description:A Standard reaction mixture (200 uL/well) containing 50 mM potassium phosphate buffer (pH 6.5), 20mM ascorbic acid (neutralized with NaOH), 200 ug/ml...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase 2(Human)
University Health Network

US Patent
LigandChemical structure of BindingDB Monomer ID 50287562BDBM50287562(CHEMBL4173383 | US11572354, Compound 10e)
Affinity DataIC50: 2.00E+5nMAssay Description:A Standard reaction mixture (200 uL/well) containing 50 mM potassium phosphate buffer (pH 6.5), 20mM ascorbic acid (neutralized with NaOH), 200 ug/ml...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent